ArticleCase reports in dentistry2026
A Case Series on the Combined Use of Zinc L-Carnosine and Nd:YAG Photobiomodulation for Radiation-Induced Oral Mucositis: Pain Reduction and Lesion Improvement.
Article in Case reports in dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation-induced oral mucositis (RIOM) is a severe complication in patients with head and neck cancer (HNC) undergoing radiotherapy (RT). Despite several proposed strategies for prevention and treatment, the results remain inconsistent and unpredictable. A combined approach with zinc L-carnosine (ZnC) mouthwash and Nd:YAG laser photobiomodulation (PBM) was evaluated in three patients affected by RIOM, treated at the Unit of Oral Medicine, Pathology and Laser-assisted Surgery of the University of Parma, Italy. One patient had oropharyngeal cancer, one had tongue cancer, and one had soft palate cancer. Two patients presented with World Health Organization (WHO) grade III mucositis, and one with WHO grade II mucositis. The percentage reduction in oral lesions was calculated using Fiji software. All patients reported clinical improvement and a reduction in algic symptoms. A significant decrease in pain was observed after only 2 days, while complete mucosal healing was achieved within 3 weeks. These preliminary results suggest that the combined use of ZnC and Nd:YAG laser PBM may be a promising therapeutic option for patients affected by RIOM, warranting further investigation in larger clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.